Phillip G. Febbo net worth and biography

Phillip Febbo Biography and Net Worth

SVP of Illumina
Dr. Phillip G. Febbo M.D. serves as Senior Vice President, Chief Medical Officer of the Company. For the past 25 years, Dr. Febbo has worked at leading institutions throughout the United States, most recently serving as CMO of Genomic Health (NASDAQ:GHDX). Prior to joining Genomic Health, Dr. Febbo served as Professor of Medicine and Urology at the University of California, San Francisco (UCSF), where his laboratory focused on using genomics to understand the biology and clinical behavior of prostate cancer, and his clinical practice focused on genitourinary oncology. While at UCSF, Dr. Febbo was the co-leader of the Prostate Cancer Program at the Helen Diller Family Comprehensive Cancer Center and the Program Principal Investigator of the Translational Research Program for the Alliance for Clinical Trials in Oncology. Dr. Febbo holds a Bachelor of Arts degree in Biology from Dartmouth College, received his M.D. degree at UCSF, and completed his internal medicine residency at the Brigham and Women's Hospital. After his fellowship in medical oncology at the Dana-Farber Cancer Institute, he was an Attending Physician in the Genitourinary Oncology Center at Dana-Farber, Instructor at Harvard Medical School, and a post-doctoral fellow in Dr. Todd Golub's laboratory at Dana-Farber, as well as the Whitehead Institute Center for Genomic Research of MIT (now the Broad Institute). In 2004, Dr. Febbo moved to Duke University Medical Center's Institute of Genome Sciences and Policy. He has been a member of the American Society for Clinical Investigation since 2009.

What is Phillip G. Febbo's net worth?

The estimated net worth of Phillip G. Febbo is at least $1.10 million as of April 6th, 2022. Dr. Febbo owns 5,774 shares of Illumina stock worth more than $1,101,621 as of October 1st. This net worth evaluation does not reflect any other investments that Dr. Febbo may own. Learn More about Phillip G. Febbo's net worth.

How do I contact Phillip G. Febbo?

The corporate mailing address for Dr. Febbo and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Phillip G. Febbo's contact information.

Has Phillip G. Febbo been buying or selling shares of Illumina?

Phillip G. Febbo has not been actively trading shares of Illumina in the last ninety days. Most recently, Phillip G. Febbo sold 1,988 shares of the business's stock in a transaction on Wednesday, April 6th. The shares were sold at an average price of $360.01, for a transaction totalling $715,699.88. Following the completion of the sale, the senior vice president now directly owns 5,774 shares of the company's stock, valued at $2,078,697.74. Learn More on Phillip G. Febbo's trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 19 times. They sold a total of 21,102 shares worth more than $8,202,908.23. The most recent insider tranaction occured on July, 7th when SVP Alexander Aravanis sold 539 shares worth more than $107,800.00. Insiders at Illumina own 0.1 % of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 7/7/2022.

Phillip G. Febbo Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/6/2022Sell1,988$360.01$715,699.885,774View SEC Filing Icon  
11/8/2021Sell1,000$406.83$406,830.00View SEC Filing Icon  
6/11/2021Sell1,000$447.59$447,590.005,151View SEC Filing Icon  
4/16/2020Sell173$300.00$51,900.002,490View SEC Filing Icon  
11/14/2019Sell155$300.00$46,500.001,506View SEC Filing Icon  
See Full Table

Phillip G. Febbo Buying and Selling Activity at Illumina

This chart shows Phillip G Febbo's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Read More

Today's Range

Now: $190.79
Low: $183.65
High: $194.22

50 Day Range

MA: $206.33
Low: $184.12
High: $227.44

2 Week Range

Now: $190.79
Low: $173.45
High: $428.00

Volume

2,775,675 shs

Average Volume

1,292,445 shs

Market Capitalization

$29.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16